LGALS1 and glioma: This study is the first in the Turkish population to evaluate serum GAL-1, -3, and − 8 levels together clinically in glioma tumor pathologies with high angiogenic activity, and it sheds light on the role of increased serum galectin levels in the promotion of LGGs to HGG.